VGN logo

Vinci Gen S.A. Stock Price

WSE:VGN Community·zł3.3m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

VGN Share Price Performance

zł0.31
-0.15 (-33.04%)
zł0.31
-0.15 (-33.04%)
Price zł0.31

VGN Community Narratives

There are no narratives available yet.

Snowflake Analysis

Proven track record with adequate balance sheet.

3 Risks
1 Reward

Vinci Gen S.A. Key Details

zł52.6k

Revenue

zł0

Cost of Revenue

zł52.6k

Gross Profit

-zł17.2k

Other Expenses

zł69.8k

Earnings

Last Reported Earnings
Sep 30, 2024
Next Reporting Earnings
n/a
0.0065
100.00%
132.60%
26.5%
View Full Analysis

About VGN

Founded
2010
Employees
1
CEO
Michal Marczuk
WebsiteView website
ipo.com.pl

Vinci Gen S.A. engages in the building and development of an integrated ecosystem of health services using modern genetics and imaging diagnostics in Poland, the European Union and global markets. Its areas of activity are NIPT prenatal diagnostics, genetic cancer diagnostics, artificial intelligence in diagnostics, telemedicine and mobile applications, medical marijuana and supportive therapies, and translational medicine and scientific cooperation. Vinci Gen S.A. was formerly known as Movie Games VR Spólka Akcyjna and changed its name to Vinci Gen S.A. in July 2025. Vinci Gen S.A. was incorporated in 2010 and is headquartered in Warsaw, Poland.

Recent VGN News & Updates

Recent updates

No updates